The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF)

B. Weingard (66421 Homburg (Saar), Germany), F. Trudzinski (69126 Heidelberg, Germany), S. Schneitler (66421 Homburg (Saar), Germany), S. Becker (66421 Homburg (Saar), Germany), H. Schäfers (66421 Homburg (Saar), Germany), R. Bals (66421 Homburg (Saar), Germany), H. Wilkens (66421 Homburg (Saar), Germany), F. Langer (66421 Homburg (Saar), Germany)

Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Session: Optimising outcomes of lung transplantation: how to move forward?
Session type: Oral Presentation
Number: 2910

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Weingard (66421 Homburg (Saar), Germany), F. Trudzinski (69126 Heidelberg, Germany), S. Schneitler (66421 Homburg (Saar), Germany), S. Becker (66421 Homburg (Saar), Germany), H. Schäfers (66421 Homburg (Saar), Germany), R. Bals (66421 Homburg (Saar), Germany), H. Wilkens (66421 Homburg (Saar), Germany), F. Langer (66421 Homburg (Saar), Germany). The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF). 2910

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Improved survival at low lung function in cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx)
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Long-term evaluation of the response to aggressive treatment at the first colonization of P.aeruginosa in cystic fibrosis (CF)
Source: Eur Respir J 2001; 18: Suppl. 33, 126s
Year: 2001

Early re-colonization with pseudomonas aeruginosa (PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


The need for lung transplantation in cystic fibrosis (CF) in the era of new treatment
Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Year: 2020


Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018



Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015


Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Ciliary function in paediatric non cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Cytokine and chemokine release in response to Pseudomonas aeruginosa (PA), by bronchial epithelium of the native airway and transplanted lung of paediatric cystic fibrosis (CF) lung transplant recipients
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Difficult issues in the selection of cystic fibrosis patients for lung transplantation
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=139
Year: 2006

Survival and lung function in double lung transplant recipients with cystic fibrosis
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Survival benefit of lung transplantation for cystic fibrosis in Norway
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019


The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis
Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018
Year: 2019